ScholarIQanswers from OpenAlex & ORCID
Weidong Li
ResearcherPublications, citations & collaboration network
Weidong Li is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Weidong Li have?
ScholarIQindexed works
Weidong Li has 637 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Weidong Li have?
ScholarIQcitation count
Weidong Li has 18,435 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Weidong Li?
ScholarIQh-index
Weidong Li has an h-index of 60 in OpenAlex.
What is the i10-index of Weidong Li?
ScholarIQi10-index
Weidong Li has an i10-index of 268 in OpenAlex.
What is the ORCID of Weidong Li?
ScholarIQorcid
The ORCID for Weidong Li is on the source record.
What is the OpenAlex record for Weidong Li?
ScholarIQopenalex
The OpenAlex for Weidong Li is on the source record.
What are the most-cited papers on Weidong Li?
ScholarIQmost cited works
Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome
Yongyong Shi, Han Zhao, Yuhua Shi, Yunxia Cao, Dongzi Yang, Zhiqiang Li, Bo Zhang, Xiaoyan Liang, Tao Li, Jianhua Chen, Jiawei Shen, Junzhao Zhao, You Li, Xuan Gao, Dongyi Zhu, Xiaoming Zhao, Ying Yan, Yingying Qin, Wenjin Li, Junhao Yan, Qingzhong Wang, Junli Zhao, Ling Geng, Jinlong Ma, Yueran Zhao, Guang He, Aiping Zhang, Shuhua Zou, Aijun Yang, Jiayin Liu, Weidong Li, Baojie Li, Chunling Wan, Ying Qin, Juanzi Shi, Jing Yang, Hong Jiang, Jine Xu, Xiujuan Qi, Yun Sun, Yajie Zhang, Cuifang Hao, Xiuqing Ju, Dongni Zhao, Chune Ren, Xiu‐Qing Li, Wei Zhang, Yiwen Zhang, Jiangtao Zhang, Di Wu, Changming Zhang, Lin He, Zi‐Jiang Chen
Arousal effect of orexin A depends on activation of the histaminergic system
Zhi‐Li Huang, Wei‐Min Qu, Weidong Li, Takatoshi Mochizuki, Naomi Eguchi, Takeshi Watanabe, Yoshihiro Urade, Osamu Hayaishi
Genome-wide association analysis identifies 30 new susceptibility loci for schizophrenia
Zhiqiang Li, Jianhua Chen, Hao Yu, Lin He, Yifeng Xu, Dai Zhang, Qizhong Yi, Changgui Li, Xingwang Li, Jiawei Shen, Zhijian Song, Weidong Ji, Meng Wang, Juan Zhou, Boyu Chen, Yahui Liu, Jiqiang Wang, Peng Wang, Ping Yang, Qingzhong Wang, Guoyin Feng, Benxiu Liu, Wensheng Sun, Baojie Li, Guang He, Weidong Li, Chunling Wan, Qi Xu, Wenjin Li, Zujia Wen, Ke Liu, Fang Huang, Jue Ji, Stephan Ripke, Weihua Yue, Patrick F. Sullivan, Michael O‘Donovan, Yongyong Shi
Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
Yunpeng Yang, Song Qu, Jingao Li, Chaosu Hu, Mingjun Xu, Weidong Li, Ting Zhou, Liangfang Shen, Hui Wu, Jinyi Lang, G. Hu, Zhanxiong Luo, Zhichao Fu, Shenhong Qu, Weineng Feng, Xiaozhong Chen, Shaojun Lin, Weimin Zhang, Xiaojiang Li, Yan Sun, Zhixiong Lin, Qin Lin, Lei Feng, Jianting Long, Jinsheng Hong, Xiaoming Huang, Lingzhi Zeng, Peiguo Wang, Xiaohui He, Ben Zhang, Qing Yang, Xiao‐Jing Zhang, Jianjun Zou, Wenfeng Fang, Li Zhang
Connections between the human gut microbiome and gestational diabetes mellitus
Yashu Kuang, Jinhua Lu, Shenghui Li, Junhua Li, Mingyang Yuan, Jianrong He, Niannian Chen, Wanqing Xiao, Songying Shen, Lan Qiu, Ying-Fang Wu, Cui‐Yue Hu, Yanyan Wu, Weidong Li, Qiaozhu Chen, Hong‐Wen Deng, Christopher J. Papasian, Huimin Xia, Xiu Qiu